> Accueil / Recherche

REFERENCES DE L’ANNEE

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 associated lymphoproliferative disorders. Oksenhendler E, Boutboul D, Galicier L. Blood. 2019 Jan 4.

Recurrent PDGFRB mutations in unicentric Castleman disease. Li Z, Lan X, Li C, Zhang Y, Wang Y, Xue W, Lu L, Jin M, Zhou Z, Wang X, Li L, Zhang L, Li X, Fu X, Sun Z, Wu J, Zhang X, Yu H, Nan F, Chang Y, Yan J, Wu X, Wang G, Zhang D, Zhang Y, Young KH, Zhang M. Leukemia. 2019 Jan 3.

A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease. Baker TS, Gambino KJ, Schriefer L, Lim JY, Steinberg KM, Fajgenbaum DC, Martín García-Sancho A, Byun M. Blood Adv. 2018 Nov 13;2(21):2959-2963.

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Fajgenbaum DC. Blood. 2018 Nov 29;132(22):2323-2330.

Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data. Morra DE, Pierson SK, Shilling D, Nemat S, Appiani C, Guilfoyle M, Tendler C, van Rhee F, Fajgenbaum DC. Br J Haematol. 2018 Sep 11.

ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease. Van Nieuwenhove E, Humblet-Baron S, Van Eyck L, De Somer L, Dooley J, Tousseyn T, Hershfield M, Liston A, Wouters C. Pediatrics. 2018 Sep;142(3). 2017-2266.

Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Nagy A, Bhaduri A, Shahmarvand N, Shahryari J, Zehnder JL, Warnke RA, Mughal T, Ali S, Ohgami RS. Blood Adv. 2018 Mar 13;2(5):481-491.

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC. Blood. 2018 Nov 15;132(20):2115-2124. Epub 2018 Sep 4. Review.

The full spectrum of Castleman disease: 273 patients studied over 20 years.Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, Vercellino L, Meignin V, Gérard L, Galicier L. Br J Haematol. 2018 Jan;180(2):206-216

Clinical and molecular characteristics of unicentric mediastinal Castleman disease. Legras A, Tallet A, Didelot A, Cazes A, Danel C, Hin A, Borie R, Crestani B, Castier Y, Bagan P, Le Pimpec-Barthes F, Riquet M, Blons H, Mordant P. J Thorac Dis. 2018 Apr;10(4):2079-2088.